Dow Down 1.12% Nasdaq Down 1.14%

Veracyte, Inc. (VCYT)

-NasdaqGM
9.29 Down 0.46(4.72%) 12:35PM EDT - Nasdaq Real Time Price
Prev Close:9.75
Open:9.68
Bid:9.28 x 100
Ask:9.31 x 200
1y Target Est:19.75
Beta:N/A
Earnings Date:Nov 24 - Nov 28 (Est.)
Day's Range:9.24 - 9.84
52wk Range:9.22 - 19.00
Volume:53,242
Avg Vol (3m):117,566
Market Cap:199.61M
P/E (ttm):N/A
EPS (ttm):-1.78
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for VCYT

Comparison

Symbol% ChgMkt Cap
VCYTDown 4.72%199.61M
LHUp 0.02%8.64B
DGXUp 0.36%8.79B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):7.33
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.31
Quarterly EPS Est (Sep-14) :-0.34
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Veracyte, Inc. operates as a diagnostics company in the field of molecular cytology to enhance patient outcomes and lower healthcare costs. It provides Afirma Thyroid FNA Analysis, a solution that consists of its Gene Expression Classifier, which ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback